Redefining standards: a comprehensive systematic review of practice changing advances in GU oncology from ASCO and ESMO 2025
BackgroundThe year 2025 has been a transformative moment in GU oncology, with paradigm-shifting clinical trial results presented at major conferences and rapidly published. These developments are recasting therapeutic standards across bladder, kidney, prostate, penile, and testicular cancers through...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2026-04-01
|
| Seri Bilgileri: | Frontiers in Endocrinology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fendo.2026.1780259/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|